You Searched For "Coronavirus drugs" and got 18 results
Sort By:
2 leading disease modelers predict low COVID rates this summer — but we may need new vaccines by fall
Infectious disease modelers told the FDA we're "peaking" at around 80% immunity against Omicron now…
Hilary Brueck
FDA advisors call for an end to never-ending booster shots as they try to map out a strategy for living with COVID
"We simply can't be boosting people as frequently as we are," the FDA's Peter Marks acknowledged on…
Hilary Brueck
The ivermectin battle isn't over: COVID-19 doctors are prescribing the drug in plain sight
Misinformation campaigns and hero complexes drive doctors to dole out ivermectin for COVID-19, desp…
Aria Bendix
An aggressive HIV variant silently spread in the Netherlands for 2 decades — a cautionary tale for the current pandemic
European researchers identified 109 people in the Netherlands with an aggressive HIV variant dating…
Aria Bendix
Former FDA commissioner says schools should not mandate boosters for children
"I think this should be left up to the discretion of parents and their physicians," Scott Gottlieb …
Yelena Dzhanova
Merck says it'll ask regulators to authorize the first antiviral pill designed to treat COVID-19 after a trial found it halved the risk of hospitalization or death
Merck and Ridgeback on Friday morning said they'd apply for emergency FDA authorization for the dru…
Grace Dean
FDA authorizes boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and others at high risk from COVID-19
The hope is that booster shots will help protect those most at risk as the pandemic continues to ra…
Andrew Dunn
Inside the battle that's brewing as psychedelic companies fight for patent rights
These are Insider's biggest healthcare stories for November 9.
Leah Rosenbaum
Former FDA commissioner says 'we're close to the end of the pandemic phase' as kids get vaccinated and COVID-19 pills emerge
Gottlieb on Sunday said he expected the Delta variant to continue to spread throughout the country,…
Connor Perrett
Why so many drug companies are now RNA companies
These are Insider's biggest healthcare stories for October 6.
Leah Rosenbaum
Omicron has drug companies preparing for the worst. Here are their plans to counterattack the newest COVID-19 variant.
Experts fear that the newest variant may make vaccines and therapies less effective. "On the face o…
Andrew Dunn
How a group with right-wing ties duped tens of thousands of Americans into buying COVID-19 drugs that don't work
Patients may have spent $6.7 million for medical advice and $8.5 million for prescriptions, The Int…
Aria Bendix
Lilly paused it coronavirus antibody drug trial
These are Business Insider's biggest healthcare stories for October 14.
Lydia Ramsey Pflanzer
CDC advisors raise concerns about 'over-vaccination' and ask the White House for more data to show boosters are needed
A select few may derive real benefits from a third shot, but other Americans may not, said an indep…
Hilary Brueck
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
Unvaccinated Texas GOP gubernatorial candidate Allen West is ill with COVID-19 and medicating with unproven drugs
West said he will most likely have to be hospitalized after his oxygen levels dropped and x-rays sh…
Sarah Al-Arshani
FDC launches two variants of COVID-19 drug Favipiravir in India at ₹55 per tablet
FDC has launched two variants of Favipiravir in India at ₹55 per tablet under the brand names PiFLU…
Biocon to launch drug for COVID-19 patients at ₹ 8,000 per vial
Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatme…